米卡芬净治疗念珠菌尿症：病例系列报道
Micafungin in the treatment of candiduria: A case series.
作者信息
Kane Lauren E, Muzevich Katie M
机构信息
Department of Pharmacy, VCU Health, Richmond, VA, United States.
出版信息
Med Mycol Case Rep. 2016 Jan 30;11:5-8. doi: 10.1016/j.mmcr.2016.01.003. eCollection 2016 Mar.
Abstract
Echinocandin antifungal agents are not routinely recommended for the treatment of candiduria due to low urine concentrations and a paucity of clinical data supporting this indication. This report presents five cases describing the use of micafungin for the treatment of candiduria. Each patient received parenteral micafungin for a minimum of 6 days and had resolution of baseline fungal within 30 days of treatment completion.
摘要
由于尿液浓度低且缺乏支持该适应症的临床数据，棘白菌素类抗真菌药物通常不推荐用于治疗念珠菌尿症。本报告介绍了5例使用米卡芬净治疗念珠菌尿症的病例。每位患者接受静脉注射米卡芬净至少6天，并且在治疗完成后30天内基线真菌得到清除。
相似文献
1
Micafungin in the treatment of candiduria: A case series.米卡芬净治疗念珠菌尿症：病例系列报道
Med Mycol Case Rep. 2016 Jan 30;11:5-8. doi: 10.1016/j.mmcr.2016.01.003. eCollection 2016 Mar.
2
Micafungin treatment and eradication of candiduria among hospitalized patients.米卡芬净治疗并根除住院患者念珠菌尿症
Int Urol Nephrol. 2016 Nov;48(11):1881-1885. doi: 10.1007/s11255-016-1410-0. Epub 2016 Sep 1.
3
Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.增加米卡芬净剂量成功根除肝肾移植受者慢性症状性克柔念珠菌尿路感染：病例报告及文献复习
Transpl Infect Dis. 2019 Aug;21(4):e13118. doi: 10.1111/tid.13118. Epub 2019 Jun 3.
4
Treatment of candiduria with micafungin: A case series.米卡芬净治疗尿念珠菌病：病例系列。
Can J Infect Dis Med Microbiol. 2007 Mar;18(2):149-50. doi: 10.1155/2007/768734.
5
Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study.米卡芬净与卡泊芬净治疗血液恶性肿瘤中性粒细胞减少症患者发热性中性粒细胞减少症的回顾性研究。
Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):299-304. doi: 10.1155/2014/983724.
6
[Evaluation of Micafungin Use in Children].[儿童米卡芬净使用情况评估]
Mikrobiyol Bul. 2020 Jan;54(1):120-134. doi: 10.5578/mb.68832.
7
Evaluation of the Treatment of Candiduria at an Academic Medical Center.一所学术医疗中心念珠菌尿症治疗的评估
Am J Ther. 2016 Nov/Dec;23(6):e1774-e1780. doi: 10.1097/MJT.0000000000000021.
8
Epidemiological profile of patients hospitalized with candiduria in the Central-Western region of Brazil.巴西中西部地区念珠菌尿症住院患者的流行病学概况。
Rev Iberoam Micol. 2019 Oct-Dec;36(4):175-180. doi: 10.1016/j.riam.2019.04.006. Epub 2019 Nov 4.
9
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.棘白菌素类药物在美国医院治疗真菌感染中的使用情况及剂量模式。
Curr Med Res Opin. 2009 Feb;25(2):385-93. doi: 10.1185/03007990802619599.
10
Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.评估卡泊芬净或米卡芬净作为成人持续性发热性中性粒细胞减少症患者经验性抗真菌治疗的效果：回顾性、观察性、连续队列分析。
Clin Ther. 2010 Apr;32(4):637-48. doi: 10.1016/j.clinthera.2010.04.005.
引用本文的文献
1
Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit.新生儿重症监护病房中棘白菌素类药物的应用前景
Antibiotics (Basel). 2024 Dec 12;13(12):1209. doi: 10.3390/antibiotics13121209.
2
Micafungin Is an Efficient Treatment of Multi Drug-Resistant Urosepsis: A Case Report.米卡芬净是多重耐药性泌尿道感染的有效治疗药物：病例报告
J Fungi (Basel). 2021 Sep 24;7(10):800. doi: 10.3390/jof7100800.
3
High prevalence of asymptomatic nosocomial candiduria due to among hospitalized patients with heart failure: a matter of some concern?心力衰竭住院患者中由……引起的无症状医院念珠菌尿症患病率高：这是一个值得关注的问题吗？
Curr Med Mycol. 2020 Dec;6(4):1-8. doi: 10.18502/cmm.6.4.5327.
4
Are Antimicrobial Peptide Dendrimers an Escape from ESKAPE?抗菌肽树枝状大分子能否摆脱ESKAPE病原体的困扰？
Adv Wound Care (New Rochelle). 2020 May 19;9(7):378-95. doi: 10.1089/wound.2019.1113.
5
Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.无症状念珠菌尿症住院患者的过度治疗：一项多机构研究。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01464-17. Print 2018 Jan.
6
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.米卡芬净的临床药代动力学和药效学。
Clin Pharmacokinet. 2018 Mar;57(3):267-286. doi: 10.1007/s40262-017-0578-5.
本文引用的文献
1
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.棘白菌素类药物在念珠菌生物膜相关血管导管感染中的作用：体外和体内模型系统。
Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S618-21. doi: 10.1093/cid/civ815.
2
Echinocandin Resistance in Candida.念珠菌中的棘白菌素耐药性
Clin Infect Dis. 2015 Dec 1;61 Suppl 6(Suppl 6):S612-7. doi: 10.1093/cid/civ791.
3
Candiduria in Catheter Associated Urinary Tract Infection with Special Reference to Biofilm Production.导尿管相关尿路感染中的念珠菌尿症，特别提及生物膜的产生
J Clin Diagn Res. 2015 Oct;9(10):DC11-3. doi: 10.7860/JCDR/2015/13910.6690. Epub 2015 Oct 1.
4
Is Fluconazole or an Echinocandin the Agent of Choice for Candidemia.氟康唑或棘白菌素是念珠菌血症的首选药物吗？
Ann Pharmacother. 2015 Sep;49(9):1068-74. doi: 10.1177/1060028015590838. Epub 2015 Jun 23.
5
Echinocandin resistance: an emerging clinical problem?棘白菌素耐药性：一个新出现的临床问题？
Curr Opin Infect Dis. 2014 Dec;27(6):484-92. doi: 10.1097/QCO.0000000000000111.
6
Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.在生理血清浓度下，米卡芬净对白色念珠菌和近平滑念珠菌生物膜具有抗真菌活性。
Antimicrob Agents Chemother. 2014 Sep;58(9):5581-4. doi: 10.1128/AAC.02738-14. Epub 2014 Jun 23.
7
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin.1例光滑念珠菌所致严重尿源性脓毒症经米卡芬净成功治疗
Med Mycol Case Rep. 2014 May 10;5:1-3. doi: 10.1016/j.mmcr.2014.04.003. eCollection 2014 Jul.
8
Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.引起医院获得性尿念珠菌病的念珠菌属种的分布及抗真菌药敏性。
Med Mycol. 2012 Jul;50(5):529-32. doi: 10.3109/13693786.2011.618996. Epub 2011 Oct 11.
9
Candida urinary tract infections--treatment.念珠菌性尿路感染——治疗。
Clin Infect Dis. 2011 May;52 Suppl 6:S457-66. doi: 10.1093/cid/cir112.
10
Candida urinary tract infections--epidemiology.念珠菌性尿路感染——流行病学。
Clin Infect Dis. 2011 May;52 Suppl 6:S433-6. doi: 10.1093/cid/cir109.
Zotero 插件